Search results
Sobi scores EU approval for haemophilia A replacement therapy Altuvoct
Pharmaceutical Technology via Yahoo Finance· 4 days agoIt grants a ten-year market exclusivity to the therapy, compared with...exclusivity that drugs...
FDA Expands Sarepta's (SRPT) DMD Gene Therapy Label
Zacks via Yahoo Finance· 2 days agoFollowing the label expansion, Sarepta's (SRPT) Elevidys is approved to treat all DMD patients aged four years and older, regardless of ambulation...
Elion secures $81m to advance antifungal therapy
Pharmaceutical Technology via Yahoo Finance· 6 days agoElion’s antifungal therapy SF001 targets aspergillosis, which can be caused by Aspergillus fumigatus, a pathogen of critical priority as per the WHO.
iOnctura raises nearly $86m in Series B to fund Phase II cancer trials
Pharmaceutical Technology via Yahoo Finance· 3 days agoIn January, roginolisib received an orphan drug designation from the US Food and Drug Administration...
Mitsubishi Tanabe Pharma America Celebrates Second Anniversary of RADICAVA ORS® (edaravone) Launch...
WWTI Watertown· 6 days ago"Helping people who are living with serious and debilitating diseases is our greatest motivator, and we are honored that for two years, RADICAVA ORS has provided people with ALS an oral treatment ...
Tharimmune Announces Positive Type C Meeting with FDA for Phase 2 Program for TH104, its Lead...
The Joplin Globe· 7 days agoFood and Drug Administration (FDA) for its Phase 2 clinical trial with TH104, a proprietary transmucosal buccal film embedded with the approved, active ...
Exploring Undervalued Small Caps With Insider Buying In Hong Kong June 2024
Simply Wall St. via Yahoo Finance· 7 days agoAs of June 2024, the Hong Kong market reflects a cautious sentiment, mirroring broader global...
Europe OKs Marketing of Hemophilia A Drug
Medscape· 3 days agoAltuvoct is used to treat and prevent bleeds and for perioperative prophylaxis in people of all ages with hemophilia A.
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024
InvestorPlace· 5 days agoAs the main stock indices like the S&P 500 and Nasdaq continue to climb, penny stocks are becoming...
BrainStorm appoints new COO ahead of ALS study By Investing.com
Investing.com· 4 days agoBrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a developer of adult stem cell therapies for...